January 20, 2016
German Biofrontera leaving London Stock Exchange
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…
Pharmaceuticals, Biotechnology and Life Sciences
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…